Chemical engineers have trained a neural network model to plan synthetic routes to any target molecule, optimizing user-specified objectives such as cost, time, and sustainability. Researchers, from ...
TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to as "Elix") commenced joint ...
Elix Inc. has teamed up with Shionogi & Co. Ltd. to validate a retrosynthetic analysis model for drug discovery that will employ chemical reaction data from Shionogi to explore various routes to ...
This module covers aldehydes and ketones as the substrates and products of redox reactions. Structure is explained with both Lewis structures and molecular orbitals to discuss mechanisms in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results